Table 24-3.
Diseases and Risk Factors | Both Sexes | Whites
|
Blacks
|
Mexican Americans
|
Hispanics/ Latinos
|
Asians: Both Sexes | American Indian/ Alaska Native: Both Sexes | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Males | Females | Males | Females | Males | Females | Males | Females | ||||
Total CVD | |||||||||||
Prevalence, 2008* | 82.6 M (36.2%) | 37.4% | 33.8% | 44.8% | 47.3% | 30.7% | 30.9% | N/A | N/A | N/A | N/A |
Mortality, 2008† | 811.9 K | 335.2 K | 360.4 K | 46.8 K | 49.8 K | N/A | N/A | N/A | N/A | N/A | N/A |
CHD | |||||||||||
Prevalence, CHD, 2008* | 16.3 M (7.0%) | 8.5% | 5.8% | 7.9% | 7.6% | 6.3% | 5.6% | 5.2%|| | 4.9%|| | 5.9%||# | |
Prevalence, MI, 2008* | 7.9 M (3.1%) | 4.3% | 2.1% | 4.3% | 2.2% | 3.0% | 1.1% | N/A | N/A | N/A | N/A |
Prevalence, AP, 2008* | 9.0 M (3.9%) | 3.8% | 3.7% | 3.3% | 5.6% | 3.6% | 3.7% | N/A | N/A | N/A | N/A |
New and recurrent CHD‡§ | 1.26 M | 675.0 K | 445.0 K | 70.0 K | 65.0 K | N/A | N/A | N/A | N/A | N/A | N/A |
Mortality, CHD, 2008† | 405.3 K | 189.3 K | 164.5 K | 21.4 K | 20.5 K | N/A | N/A | N/A | N/A | N/A | N/A |
Mortality, MI, 2008† | 134.0 K | 63.8 K | 53.3 K | 6.9 K | 6.9 K | N/A | N/A | N/A | N/A | N/A | N/A |
Stroke | |||||||||||
Prevalence, 2008* | 7.0 M (3.0%) | 2.4% | 3.3% | 4.5% | 4.4% | 2.0% | 2.7% | 2.6%|| | 2.0%|| | 5.9%||# | |
New and recurrent strokes† | 795.0 K | 325.0 K | 365.0 K | 45.0 K | 60.0 K | N/A | N/A | N/A | N/A | N/A | N/A |
Mortality, 2008† | 134.1 K | 44.4 K | 68.8 K | 7.2 K | 9.5 K | N/A | N/A | N/A | N/A | N/A | N/A |
HBP | |||||||||||
Prevalence, 2008* | 76.4 M (33.5%) | 33.9% | 31.3% | 43.0% | 45.7% | 27.8% | 28.9% | 24.7%|| | 20.5%|| | 30.0%|| | |
Mortality, 2008† | 61.0 K | 19.6 K | 26.3 K | 6.4 K | 7.0 K | N/A | N/A | N/A | N/A | N/A | N/A |
HF | |||||||||||
Prevalence, 2008* | 5.7 M (2.4%) | 2.7% | 1.8% | 4.5% | 3.8% | 2.3% | 1.3% | N/A | N/A | N/A | N/A |
Mortality, 2008† | 56.8 K | 20.3 K | 30.2 K | 2.4 K | 3.1 K | N/A | N/A | N/A | N/A | N/A | N/A |
Smoking | |||||||||||
Prevalence, 2010|| | 44.1 M (19.3%) | 23.0% | 20.5% | 23.4% | 16.7% | 12.0% | 15.2% | 9.0% | 9.3% | 26.6% | |
Blood cholesterol | |||||||||||
Prevalence, 2008 | |||||||||||
Total cholesterol ≥200 mg/dL* | 98.8 M (44.4%) | 41.2% | 47.0% | 37.0% | 41.2% | 50.1% | 46.5% | N/A | N/A | N/A | N/A |
Total cholesterol ≥240 mg/dL* | 33.6 M (15.0%) | 13.7% | 16.9% | 9.7% | 13.3% | 16.9% | 14.0% | N/A | N/A | N/A | N/A |
LDL cholesterol ≥130 mg/dL* | 71.3 M (31.9%) | 30.5% | 32.0% | 34.4% | 27.7% | 41.9% | 31.6% | N/A | N/A | N/A | N/A |
HDL cholesterol <40 mg/dL* | 41.8 M (18.9%) | 29.5% | 10.1% | 16.6% | 6.6% | 31.7% | 12.2% | N/A | N/A | N/A | N/A |
PA¶ | |||||||||||
Prevalence, 2010|| | 20.7% | 21.3% | 17.2% | 13.2% | 14.4% | 17.8% | 12.5% | ||||
Overweight and obesity | |||||||||||
Prevalence, 2008 | |||||||||||
Overweight and obesity, BMI ≥25.0kg/m2* | 149.3 M (67.3%) | 72.3% | 59.3% | 70.8% | 77.7% | 77.5% | 75.1% | N/A | N/A | N/A | N/A |
Overweight and obesity, BMI ≥30.0kg/m2* | 75.0 M (33.7%) | 32.1% | 32.8% | 37.0% | 51.0% | 31.4% | 43.4% | N/A | N/A | N/A | N/A |
DM | |||||||||||
Prevalence, 2008 | |||||||||||
Physician-diagnosed DM* | 18.3 M (8.0%) | 6.8% | 6.5% | 14.3% | 14.7% | 11.0% | 12.7% | N/A | N/A | N/A | N/A |
Undiagnosed DM* | 7.1 M (3.1%) | 3.9% | 1.9% | 4.8% | 4.0% | 6.3% | 3.8% | N/A | N/A | N/A | N/A |
Prediabetes* | 81.5 M (36.8%) | 45.4% | 27.9% | 31.6% | 27.1% | 44.9% | 34.3% | N/A | N/A | N/A | N/A |
Incidence, diagnosed DM* | 1.6 M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Mortality, 2008† | 70.6 K | 28.6 K | 27.3 K | 5.5 K | 6.6 K | N/A | N/A | N/A | N/A | N/A | N/A |
CVD indicates cardiovascular disease; M, millions; N/A, data not available; K, thousands; CHD, coronary heart disease (includes heart attack, angina pectoris chest pain, or both); MI, myocardial infarction (heart attack); AP, angina pectoris (chest pain); HBP, high blood pressure; HF, heart failure; LDL, low-density lipoprotein; HDL, high-density lipoprotein; PA, physical activity; BMI, body mass index; and DM, diabetes mellitus.
Age >20 y.
All ages.
New and recurrent MI and fatal CHD.
Age ≥35 y.
Age ≥18 y.
Met 2008 Federal PA guidelines for adults.
Figure not considered reliable.